[{"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0128-2016", "product_description": "TESTOSTERONE, Pellet, 112 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "91 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12192014@18, t12092014@37, t11252014@6, t11192014@25, t10212014@24, t10172014@18, t09252014@14, t07162015@28, t07152014@12, t07062015@13, t06042015@18, t05282015@27, t04242015@23, t03192015@35, t02242015@23, t02192015@15, t02062015@9, t01292015@27, 11052014@20, 04102015@9."}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1484-2019", "product_description": "Glutathione 100 mg/mL Inhalation Solution (PF), 45 mL vial,  Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252", "product_quantity": "45 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 06172019@3, Exp. 08/18/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M013"], "brand_name": ["ASPIRIN"], "generic_name": ["ASPIRIN 81 MG"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-434"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ASPIRIN"], "rxcui": ["318272"], "spl_id": ["29b6680a-7a7a-4b2d-e063-6394a90a7ff6"], "spl_set_id": ["56279fd2-bec3-4d77-86dd-2a3bd46c6109"], "package_ndc": ["63739-434-01", "63739-434-02"], "original_packager_product_ndc": ["69168-288"], "nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "unii": ["R16CO5Y76E"]}, "product_type": "Drugs", "event_id": "73874", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0834-2016", "product_description": "SKY Aspirin Chewable Tablets, 81 mg, Unit Dose 750 tablets (25 x 30) box, OTC, Distributed by: McKesson Packaging Service, Concord, NC 28027, NDC 63739-434-01.", "product_quantity": "1,676 boxes", "reason_for_recall": "Labeling: Label mix-up -outer carton incorrectly labeled as aspirin chewable tablets.", "recall_initiation_date": "20160412", "center_classification_date": "20160428", "termination_date": "20170317", "report_date": "20160504", "code_info": "Lot 0110701"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85888", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico", "recall_number": "D-1377-2020", "product_description": "Nystatin Oral Suspension, USP 500,000 units/5mL Cup,  Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.", "product_quantity": "380,700 cups", "reason_for_recall": "Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.", "recall_initiation_date": "20200623", "center_classification_date": "20200708", "termination_date": "20220928", "report_date": "20200715", "code_info": "Lot #: a) 619800, Exp. 12/31/2020; 626200, Exp. 01/31/2021; b) 619800X,Exp. 12/31/2020; 626200X, Exp. 01/31/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0116-2023", "product_description": "TriMix Injection (PGE1/Papaverine HCl/Phentolamine Mesylate) 100mcg/30mg/3mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11212022@7, Exp 1/5/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0605-2023", "product_description": "Cefepime for Injection, USP 2 grams per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-058-10", "product_quantity": "124,010 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0313-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 20mcg/2mg/30mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "25 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 07152016E (08/22/2016), 08012016G (09/08/2016), 09162016B (09/29/2016), 11032016B (12/09/2016), 10112016C (11/24/2016)."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019466"], "brand_name": ["DEXTROSE"], "generic_name": ["DEXTROSE MONOHYDRATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-7100"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXTROSE MONOHYDRATE"], "rxcui": ["1795609", "1795610", "1795616"], "spl_id": ["477c216c-7446-473a-892d-918faf1dc877"], "spl_set_id": ["10e98cb0-31a5-4ad1-3eaa-aa4af387a42d"], "package_ndc": ["0409-7100-68", "0409-7100-66", "0409-7100-69", "0409-7100-67", "0409-7100-04", "0409-7100-02", "0030404097", "3030409710"], "is_original_packager": [true], "unii": ["LX22YL083G"], "upc": ["003040409710"]}, "product_type": "Drugs", "event_id": "70642", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0417-2015", "product_description": "5% DEXTROSE Injection, USP, 250 mL ADD-Vantage Unit bag (NDC 0409-7100-02), UPC (01)0030404097100026; packaged in 24 bags per case pack (NDC 0409-7100-02), UPC (01)30304097100027(30)01, Rx ONLY, Hospira, Inc., Lake Forest, IL 60045.", "product_quantity": "94,440 bags", "reason_for_recall": "Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.", "recall_initiation_date": "20150305", "center_classification_date": "20150317", "termination_date": "20161209", "report_date": "20150325", "code_info": "Lot: 37-042-JT, Exp 1JAN2016", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0520-2018", "product_description": "Stanozolol USP for prescription compounding, packaged in a) 25g (NDC 58597-8525-3);b)100g (NDC 58597-8525-6); c) 500g (NDC 58597-8525-7); d)1000g (NDC 58597-8525-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "12300 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 080616-1, 4/26/2019; b) 080616-1, 4/26/2019; c) 080616-1, 4/26/2019; d) 080616-1, 4/26/2019."}, {"status": "Terminated", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72069", "recalling_firm": "Bestco, Inc.", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1419-2015", "product_description": "CVS SUGAR FREE BLACK CHERRY COUGH DROPS (MENTHOL-COUGH SUPPRESSANT), Packaged in a) 25 Drop Bags (UPC: 050428 448526) and b) 36 drop bags (UPC: 050428 476581), Over the Counter. Distributed by: CVS Pharmacy, Inc., One CVS Drive Woonsocket, RI 02895.", "product_quantity": "a) 149,856 Bags; b) 19,200 Bags.", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Presence of comingled Sugar Free Honey Lemon cough drops.", "recall_initiation_date": "20150702", "center_classification_date": "20150909", "termination_date": "20170613", "report_date": "20150916", "code_info": "a) Lot #: 50122U3, Expiry: 01/2017; Lot #: 50122U1, Expiry: 01/2017; and b) Lot #: 50122U2, Expiry: 01/2017."}, {"status": "Terminated", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96600", "recalling_firm": "Medisca Inc.", "address_1": "6641 N Belt Line Rd Ste 130", "address_2": "N/A", "postal_code": "75063-6001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide.", "recall_number": "D-0386-2025", "product_description": "Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY", "product_quantity": "161.6 grams", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250331", "center_classification_date": "20250421", "termination_date": "20251010", "report_date": "20250430", "code_info": "Lot# 201727/A/B/C/D/E & F, exp.  date 05/31/2027, product # 3066 Lot# 208475/A/B/D/E/G/H & I, exp. date 09/30/2028, product # 3066"}, {"status": "Terminated", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73284", "recalling_firm": "Keystone Laboratories Inc", "address_1": "1103 Kansas St", "address_2": "N/A", "postal_code": "38106-1913", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0726-2016", "product_description": "Medicated Better Braids, La Laque (salicylic acid) Spray, 2%,12 Fl. OZ. (355 ml.) bottle, Distributed by Keystone Laboratories, Memphis, TN  38101-2026, UPC 0 70596 00422 5.", "product_quantity": "134 cases of 12 bottles/case", "reason_for_recall": "Microbial Contamination of a Non-Sterile Products:   The product had a positive Staphylococcus aureus test result.", "recall_initiation_date": "20160208", "center_classification_date": "20160222", "termination_date": "20160525", "report_date": "20160302", "code_info": "Lot #: 9AD5", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t01-18-2017@94, Exp 4/19/2017; t01-25-2017@115,  Exp 4/26/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PROCAINE HCL 50ML MDV (CALIF) 1% INJ,  Injection, 1%, Rx only, 50mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0771-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 25/1.5 mg/15 mcg/mL;  10 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0702-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76611", "recalling_firm": "Fougera Pharmaceuticals  Inc.", "address_1": "60 Baylis Rd", "address_2": "", "postal_code": "11747-3838", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0612-2017", "product_description": "Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO.  A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60", "product_quantity": "14,665 tubes", "reason_for_recall": "Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream", "recall_initiation_date": "20170302", "center_classification_date": "20170323", "termination_date": "20180702", "report_date": "20170329", "code_info": "Lot GC9231 (exp. 05/2019); Lot GC9232 (exp. 05/2019)", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-570-2013", "product_description": "Praziquantel 56.8 mg, 50 mL vial, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "5 vials of 50mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0539-2022", "product_description": "Peppermint Antacid tablet (Calcium Carbonate 420 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-303-00", "product_quantity": "3,349,387 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Code: M303 Bulk lots: 19C042, 19C043, 19F083;  Product Code: M303A Bulk Lot: 19E105"}, {"country": "United States", "city": "West Columbia", "address_1": "4500 12th Street Ext", "reason_for_recall": "GMP Deviations: potential glass contamination", "address_2": "", "product_quantity": "1370 bags", "code_info": "Lots: FB9014A Exp. 12/09/2019; FB9017A Exp. 12/16/2019", "center_classification_date": "20191018", "distribution_pattern": "Nationwide.", "state": "SC", "product_description": "PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only  Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172  NDC: 69374-530-25", "report_date": "20191030", "classification": "Class II", "openfda": {}, "recalling_firm": "Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center", "recall_number": "D-0148-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84000", "termination_date": "20201201", "more_code_info": "", "recall_initiation_date": "20191009", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-028-2013", "product_description": "Berkley & Jensen Fiber Capsules, Fiber Laxative/Fiber Supplement, 100% Natural Psyllium Fiber, 400 capsules per bottle, Distributed by: BJWC, 25 Research Drive, Westborough, MA 01581, Made in USA, UPC 4-00016-27053-2.", "product_quantity": "3,552 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 16470, Exp 08/15"}, {"status": "Terminated", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "66233", "recalling_firm": "Tween Brands Inc", "address_1": "8323 Walton Pkwy", "address_2": "N/A", "postal_code": "43054-9522", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-353-2014", "product_description": "TODAY IS AWESOME! Justice, Cotton Candy anti bac, Ethyl Alcohol, Net Wt. 1 fl oz, Distr by Tween Brands New Albany, OH 43054 Toronto, ON L6T 3R5", "product_quantity": "47,343 bottles", "reason_for_recall": "Labeling: Label Error on Declared Strength; the label states that the product contains 62% ethyl alcohol, but the ethyl alcohol content is 20%.", "recall_initiation_date": "20130621", "center_classification_date": "20131213", "termination_date": "20140616", "report_date": "20131225", "code_info": "Style #190787 & 190868"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 18/0.6 mg/6 mcg/mL;  10 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0697-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020503"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-7296"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123111"], "spl_id": ["25dfead5-2e15-f328-e063-6294a90ac356"], "spl_set_id": ["f8a2c4b7-a162-48ab-90b0-350e4da25c66"], "package_ndc": ["0781-7296-85"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1024-2022", "product_description": "Albuterol Sulfate Inhalation Aerosol HFA 90 mcg, with Dose Indicator, 200 metered inhalations, Rx only, Distributed by: Sandoz Inc., NDC 0781-7296-85", "product_quantity": "1 aerosol", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0686-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10%, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0408-1.", "product_quantity": "167 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-896130, Exp 05/06/2023; 37-897957, Exp 05/13/2023; 37-899605, Exp 05/20/2023; 37-901357, Exp 05/27/2023"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0823-2022", "product_description": "Testosterone Cypionate 200 mg/mL (in Grapeseed Oil), Packaged in a) 10 mL Multi-Dose vial, NDC 73198-0054-10; b) 5 mL Multi-Dose vial, NDC 73198-0054-05, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.", "product_quantity": "7161 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: a) D48027 BUD: 4/27/2022,E47017 BUD: 5/17/2022, F42007 BUD: 6/7/2022, F42107 BUD: 6/7/2022, F42207 BUD: 6/7/2022, F48009 BUD: 6/9/2022, F48109 BUD: 6/9/2022, H47003 BUD: 8/3/2022; b) F24024 BUD: 6/24/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0881-2019", "product_description": "Dr. King's SafeCare Rx Shy, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955275022, NDC 57955-2751-2", "product_quantity": "13 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 091616F Exp. 09/19"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88376", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Northstar Distribution Center 4853 Crumpler Rd. Memphis, TN 38141", "recall_number": "D-0703-2021", "product_description": "Venlafaxine Tablets, USP 50 mg*, 100 Tablets  Manufactured for Northstar Rx LLC Memphis, TN 38141 Manufactured by: ALKALOIDA Chemical Company Zrt. 4440 Tiszavasvari, Kabay Janos u.29.Hungary. Product of India NDC 16714-657-01", "product_quantity": "2856 bottles", "reason_for_recall": "Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg", "recall_initiation_date": "20210729", "center_classification_date": "20210806", "termination_date": "20230608", "report_date": "20210818", "code_info": "AVK1175A, exp 9/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA072711"], "brand_name": ["SULINDAC"], "generic_name": ["SULINDAC"], "manufacturer_name": ["Epic Pharma, LLC"], "product_ndc": ["42806-011", "42806-018"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULINDAC"], "rxcui": ["198238", "198239"], "spl_id": ["fb793a0a-affa-4f9a-a5b4-aa1c84aa475e"], "spl_set_id": ["96c73bd2-4577-487d-a642-bd8f91e94c3a"], "package_ndc": ["42806-018-01", "42806-018-05", "42806-018-10", "42806-011-01", "42806-011-05", "42806-011-10"], "is_original_packager": [true], "upc": ["0342806018057", "0342806011010"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["184SNS8VUH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0582-2021", "product_description": "Sulindac Tablets, USP, 200mg 100-count bottles, Rx Only, Manufactured by: Epic Pharma, LLC, Laurelton, NY 11413, NDC 42806-011-01", "product_quantity": "92 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1578F201"}, {"status": "Terminated", "city": "La Habra", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80890", "recalling_firm": "Auro Pharmacies, Inc.", "address_1": "520 W La Habra Blvd", "address_2": "N/A", "postal_code": "90631-5308", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in USA", "recall_number": "D-1163-2018", "product_description": "Testosterone Cypionate/Enanthate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631", "product_quantity": "43 vials", "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.", "recall_initiation_date": "20180821", "center_classification_date": "20180829", "termination_date": "20200130", "report_date": "20180905", "code_info": "Lot #: 180709/21, Exp 07-Sep-18"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as    CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014;  VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014;  NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014;  traZODone HCl, Tablet, 50 mg, NDC 50111043303, P", "address_2": "", "product_quantity": "1,000 Tablets", "code_info": "PHOSPHORUS Tablet, 250 mg has the following codes    Pedigree: AD56916_1, EXP: 5/21/2014;  Pedigree: W002534, EXP: 6/3/2014;  Pedigree: AD25452_7, EXP: 5/3/2014;  Pedigree: AD54498_1, EXP: 5/20/2014;  Pedigree: W003997, EXP: 7/1/2014;  Pedigree: AD46300_8, EXP: 5/15/2014;  Pedigree: AD70639_10, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PHOSPHORUS Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980010401", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-699-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0684-2020", "product_description": "BUP 15MG/CLON 400MCG/ FENT 6000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@5 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0733-2022", "product_description": "TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable, Packaged in a multi dose 10ml vial, Formula ID 115498, APS Pharmacy", "product_quantity": "0", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lot:759312 BUD: 8/30/2022"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0724-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6092-1.", "product_quantity": "14205 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883910, Exp 05/02/2023; 37-884221, Exp 05/03/2023; 37-884756, Exp 05/05/2023; 37-885358, Exp 05/08/2023; 37-885683, Exp 05/09/2023; 37-886267, 37-886268, Exp 05/11/2023; 37-886539, Exp 05/14/2023; 37-887458, 37-887459, Exp 05/16/2023; 37-888080, Exp 05/18/2023; 37-889192, Exp 05/23/2023; 37-889575, 37-889578, Exp 05/24/2023; 37-889852, 37-889855, Exp 05/25/2023; 37-890120, 37-890126, Exp 05/28/2023; 37-891485, 37-891491, Exp 06/01/2023; 37-892901, 37-892966, Exp 06/07/2023; 37-893236, 37-893237, Exp 06/08/2023; 37-893997, Exp 06/12/2023; 37-894777, Exp 06/14/2023; 37-895317, 37-895321, 37-895323, Exp 06/18/2023; 37-896201, Exp 06/20/2023; 37-896923, Exp 06/22/2023; 37-898558, Exp 06/29/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0860-2020", "product_description": "Well at Walgreens Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed by: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC 0363-9050-00.", "product_quantity": "24 tubes", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #:8G59A, Exp. Date 06/2021"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "70614", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0404-2015", "product_description": "Oxecta(TM) (oxycodone HCl) tablets, 7.5 mg, 100 count bottles, Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc. Bristol, TN, NDC 60793-526-01", "product_quantity": "139 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20150226", "center_classification_date": "20150305", "termination_date": "20170729", "report_date": "20150311", "code_info": "Lot 13T03, Exp 12/15"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0380-2020", "product_description": "CVS Health Dry Eye Relief Lubricant Eye Drops, 0.5 FL OZ (15 mL), Distributed by: CVS Pharmacy, Inc. Woonsocket, RI 0805 Made in the USA  02895", "product_quantity": "39,288 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17215 07/19  17239 08/19  18081 03/21  18207 08/20  18274 11/21"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-863-2015", "product_description": "Procainamide HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2700 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "125 ml", "code_info": "All lots distributed between November 2014 and May 2015;    04172015@56, 10/14/2015; 04202015@32, 10/17/2015; 049057, 10/21/2015; 05052015@69 11/1/2015; 05082015@43, 11/4/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone Cypionate 200 mg/ml Anastrazole 0.5 mg/ml   Injection,  Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1644-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "A5914 Exp 12/31/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-710-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1431-2022", "product_description": "ST IVES BLKHD CLRNG GREEN TEA SCRUB 6 OZ SKU 2007787  AMBI EXFOLIATING WASH 5 OZ SKU 2097153   CC BLACKHEAD SCRUB 5 OZ SKU 2032021 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 2007787; 2097153; 2032021", "more_code_info": ""}, {"country": "United States", "city": "Decatur", "address_1": "1316 Commerce Dr", "reason_for_recall": "Subpotent", "address_2": "", "product_quantity": "a) 597 jars; b) 411 jars; c) 5 jars; d) 1004 jars: e) 76 jars; f) 1592 jars", "code_info": "Lots: a) 1804030048 Exp. 06/06/2020; 1712270019, 1802160017 Exp. 08/06/2020; 1804300021, 1806270007, 1808090056, 1904290047 Exp. 04/16/2021; 1810190004, 1812200072, 1901250024 Exp. 08/13/2021;   1902190028, 1907260018 Exp 09/14/2021;     b) 1804030049 Exp. 06/06/2020; 1712270020, 1802160018 Exp. 08/06/2020;   1804300022, 1806270008, 1808090057, 1904290048 Exp. 04/16/2021; 1810190005, 1812200073, 1901250025 Exp. 08/13/2021; 1902190029, 1907260019 Exp. 09/14/2021;     c) 1802160022 Exp. 08/06/2020; 1810190009, 1812200077 Exp. 08/13/2021; 1907260023 Exp. 09/14/2021;     d) 1804030050 Exp 06/06/2020; 1712270021, 1802160019 Exp. 08/06/2020;  1804300023, 1806270009, 1808090058, 1904290049 Exp 04/16/2021; 1810190006, 1812200074, 1901250026 Exp. 08/13/2021; 1902190030, 1907260020 Exp. 09/14/2021;     e) 1802160021 Exp. 08/06/2020; 1804300025, 1806270011, 1808090060 Exp. 04/16/2021; 1810190008 Exp. 08/13/2021; 1812200076 Exp. 08/13/2021; 1901250028 Exp. 08/13/2021; 1902190031 Exp. 09/14/2021; 1907260022 Exp. 09/14/2021; f) 1712270022 Exp. 08/06/2020; 1802160020 Exp. 08/06/2020; 1804030051 Exp. 06/06/2020; 1804300024 Exp. 04/16/2021; 1806270010 Exp. 04/16/2021; 1808090059 Exp. 04/16/2021; 1810190007 Exp. 08/13/2021; 1812200075 Exp. 08/13/2021; 1901250027 Exp. 08/13/2021; 1904290050 Exp. 04/16/2021; 1907260021 Exp. 09/14/2021", "center_classification_date": "20200115", "distribution_pattern": "United States, Australia, Canada, Israel, Philippines, Taiwan.", "state": "AL", "product_description": "Estriol USP Micronized a) 100 gm NDC 62991-2159-04; b) 1 gm NDC 62991-2159-01; c) 1 kg NDC 62991-2159-06; d) 25 gm NDC 62991-2159-03; e) 500 gm NDC 62991-2159-05; f) 5 gm NDC 62991-2159-02, Rx Only Repackaged by: Letco Medical, LLC. Decatur, AL 35601", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "Letco Medical LLC", "recall_number": "D-0780-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84686", "termination_date": "20210407", "more_code_info": "", "recall_initiation_date": "20200110", "postal_code": "35601-7539", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1133-2022", "product_description": "Morbillinum, Potency:7C, 8C, 9C, 10C 12C, 13C, 15C, 20C, 21C, 30C, 200 C,Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "72 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot# 20307, 20309", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1465-2020", "product_description": "SP, hemp oil, Berry, 300MG CBD,1 FL. OZ (30 ML) bottles, Distributed by: The Spiffy Piff", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003277", "more_code_info": ""}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78099", "recalling_firm": "Vi-Jon, Inc.", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States and Canada", "recall_number": "D-0006-2018", "product_description": "Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz, packaged in 10 fl. oz ( 296 mL) bottles, Labeled as a) CVS Health, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895; NDC 6984238038,  UPC 050428418321, b) Meijer, Dist. By Meijer Distribution, Inc. Grand Rapids, MI 49544, NDC 4125038038, UPC 708820824294, c) Life Brand, Manufactured for: Shoppers Drug Mark/Pharmaprix Toronto, UPC 057800856405", "product_quantity": "87,972 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20170913", "center_classification_date": "20171005", "termination_date": "20200116", "report_date": "20171011", "code_info": "Lot #: 0323439 Exp. 07/2018", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "6 vials", "code_info": "Lot # t11-21-2016@125, Exp 4/19/2017; t01-09-2017@105, Exp 6/18/2017; t01-18-2017@90, Exp 7/5/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 10/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection,  10mcg/30mg/1mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0738-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "1,140,564 cartons", "code_info": "Lot #: a) 10116014, Exp 6/30/2013; 10122246, Exp 7/31/2013; 10124322, Exp 9/30/2013; 10128122, Exp 11/30/2013; b) 10119852, Exp 7/31/2013; 10122249, Exp 8/31/2013; 10124321, Exp 9/30/2013; 10128118, Exp 11/30/2013; 10128120, Exp 11/30/2013.    NeoCitran Cold & Flu: 10115576, Exp 6/30/2013; 10122243, Exp 8/31/2013 and 10124319, Exp 9/30/2013; Theraflu Exthegran 10115579, 10115572, Exp 6/30/2013; 10117549, Exp 8/30/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "Theraflu (acetaminophen 325 mg, pheniramine maleate 20 mg, phenylephrine hydrochloride 10 mg) powder packets, Natural Lemon flavor, 6-count packets per carton, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622, labeled as a) Theraflu Sinus & Cold (NDC 0067-6319-06, UPC 3 0043-6319-06 7) and b) Theraflu Cold & Sore Throat (NDC 0067-6716-06, UPC 3 0043-0467-16 0).    Also packaged under foreign labels: NeoCitran Cold & Flu powder packets, Natural Source Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 05009 6; and Theraflu Exthegran powder packets, lemon flavor, packaged in a) 6-count packets per carton (UPC 7 501124 812904) and b) 10-count packets per carton (UPC 7 501124 814588), Distributed by Novartis Farmaceutica S.A. De C.V., Mexico", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-751-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040886"], "brand_name": ["PHENTERMINE HYDROCHLORIDE"], "generic_name": ["PHENTERMINE HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["55289-791"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENTERMINE HYDROCHLORIDE"], "rxcui": ["968766"], "spl_id": ["419b6194-7ef1-acbc-e063-6394a90a2315"], "spl_set_id": ["4000c00f-aa6c-4ea5-af0e-149dde3c74db"], "package_ndc": ["55289-791-07", "55289-791-14", "55289-791-15", "55289-791-21", "55289-791-28", "55289-791-30", "55289-791-60"], "original_packager_product_ndc": ["10702-026"], "upc": ["0355289791607"], "unii": ["0K2I505OTV"]}, "product_type": "Drugs", "event_id": "77915", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1118-2017", "product_description": "Phentermine Capsules, 15 mg,  a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle ( NDC 55289-791-14), c) 21-count bottle (NDC 55289-791-21), d) 30-count bottle (NDC 55289-791-30), e) 60-count bottle (NDC 55289-791-60), Packaged by PD-Rx Pharmaceuticals, Incorporated, Oklahoma City, OK. 73127 Mfg: KVK-Tech, Inc. Newtown, PA 18940", "product_quantity": "3440 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test .", "recall_initiation_date": "20170811", "center_classification_date": "20170823", "termination_date": "20200129", "report_date": "20170830", "code_info": "Lots: a) H15E22, Exp. 8/31/17; J15E02, Exp. 10/31/17. b) J15A53, Exp. 10/31/17; D16C78, Exp.12/31/17; c)J15D54, Exp. 10/31/17; d)H15B60, Exp. 8/31/17; e) J15A49, Exp. 10/31/17; C16A14, Exp. 12/31/17.", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1049-2023", "product_description": "HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2", "product_quantity": "2,228 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270675, 17-270683, Exp. 7/18/2023; 17-271147, 17-271119, Exp. 7/25/2023; 17-271339, Exp. 7/27/2023; 17-271679, Exp. 8/2/2023; 17-272202, Exp. 8/10/2023; 17-272241, Exp. 8/13/2023; 17-272375, Exp. 8/15/2023; 17-272783, Exp. 8/22/2023; 17-273438, 17-273431, Exp. 9/3/2023; 17-273615, Exp. 9/5/2023; 17-273789, 9/7/2023."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1245-2015", "product_description": "Lamotrigine Extended-Release Tablets, 25 mg Tablets, 30 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.  NDC: 64679-271-01.", "product_quantity": "5,910 Bottles", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "Lot #:  DN10114, Expiry: 11/30/2015."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077553"], "brand_name": ["TERCONAZOLE"], "generic_name": ["TERCONAZOLE"], "manufacturer_name": ["Cosette Pharmaceuticals, Inc."], "product_ndc": ["0713-0552"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["VAGINAL"], "substance_name": ["TERCONAZOLE"], "rxcui": ["198245"], "spl_id": ["ee20ae91-d9b6-6f7f-e053-2a95a90a3171"], "spl_set_id": ["38cd1718-6b3c-415d-a17f-7b399adb0ba2"], "package_ndc": ["0713-0552-73"], "is_original_packager": [true], "nui": ["N0000175487", "M0002083"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "unii": ["0KJ2VE664U"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0198-2024", "product_description": "Terconazole Vaginal Suppositories, 80 mg, 3 Suppositories with Vaginal Applicator, Rx only,  Manufactured by: Cosette Pharmaceuticals, Inc., 111 Coolidge Street, South Plainfield, NJ 07080.  NDC: 0713-0552-73", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 1014228A", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0997-2017", "product_description": "Potassium PHOSphate in 5% Dextrose Injection, 15 mMol in 250 mL in 250 mL Intravia Bag Service, Rx Only. PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5300 NDC# 61553-300-11", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lot: 171420030D, 8/21/2017"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66188", "recalling_firm": "Wellness Pharmacy, Inc.", "address_1": "3401 Independence Drive Suite 231", "address_2": "N/A", "postal_code": "35209-8326", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1030-2013", "product_description": "Dexpanthenol 250mg/ml PF, Qty: 1mL, WELLNESS PHARMACY, 1-800-227-2627", "product_quantity": "1355 units", "reason_for_recall": "The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.", "recall_initiation_date": "20130823", "center_classification_date": "20130912", "termination_date": "20140603", "report_date": "20130918", "code_info": "Lot# 130605@52, Exp. 12/2/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91977", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0528-2023", "product_description": "Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.", "product_quantity": "4574 cartons", "reason_for_recall": "Sub-potent drug: assay test result below specifications at 9-month timepoint.", "recall_initiation_date": "20230329", "center_classification_date": "20230406", "termination_date": "20250319", "report_date": "20230412", "code_info": "Lot #: R2200394 Exp. 03/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Sandpoint", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68222", "recalling_firm": "Thorne Research Inc", "address_1": "25820 Hwy 2 West", "address_2": "N/A", "postal_code": "83864", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Visit", "distribution_pattern": "Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.", "recall_number": "D-1384-2014", "product_description": "Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.", "recall_initiation_date": "20140612", "center_classification_date": "20140613", "termination_date": "20141015", "report_date": "20140625", "code_info": "All lot codes", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1353-2019", "product_description": "Pseudoephedrine Oral Solution, 30 mg in each teaspoonful, Nasal Decongestant, One Pint (473 mL) bottle, NDC: 0536-1850-85, Distributed by Rugby Laboratories, Livonia MI  48152.", "product_quantity": "1,436,904 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17H012, Exp. 08/2019; 17L011, Exp. 11/2019; 17M020, Exp. 12/2019; 18D007, Exp. 04/2020; 18J001, Exp. 09/2020."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA079193"], "brand_name": ["MIMVEY"], "generic_name": ["ESTRADIOL AND NORETHINDRONE ACETATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5455"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESTRADIOL", "NORETHINDRONE ACETATE"], "rxcui": ["1359126", "1359127", "1359129"], "spl_id": ["2704fcb9-da21-461e-b6ba-b196b2f2bf4b"], "spl_set_id": ["b1c5c06b-9ce2-4bf7-9693-e37608055a14"], "package_ndc": ["0093-5455-28", "0093-5455-42"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E", "9S44LIC7OJ"]}, "product_type": "Drugs", "event_id": "89368", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0522-2022", "product_description": "Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42", "product_quantity": "6430 cartons", "reason_for_recall": "Mislabeling", "recall_initiation_date": "20220107", "center_classification_date": "20220202", "termination_date": "20230601", "report_date": "20220209", "code_info": "Lot#: 100018610, Exp 03/2022; 100021521, Exp 09/2022; 100024575, Exp 01/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80000", "recalling_firm": "Vitalab Pharmacy, Inc", "address_1": "4045 E Bell Rd Ste 163", "address_2": "N/A", "postal_code": "85032-2240", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled product was distributed to patients throughout the United States.", "recall_number": "D-0732-2018", "product_description": "Papaverine 30mg/Phentolamine 1.5mg/Prostaglandin 50mcg/mL, sterile injectable, ST3:Papaverine 40mg/Phentolamine 3mg/Prostaglandin 60mcg/mL, Vitalab Pharmacy, Inc.", "product_quantity": "N/A", "reason_for_recall": "Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.", "recall_initiation_date": "20180424", "center_classification_date": "20180509", "termination_date": "20200123", "report_date": "20180516", "code_info": "Lot #: 03052018@54"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1628-2019", "product_description": "Asma Stopper Capsules, Distributed by Herbal Doctor Remedies, Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1000 mL in Vials", "code_info": "Lot #: 151216-33, BUD: 06/13/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "DMPS 50MG/ML (PF), 5ML Vials,  MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1180-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91921", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0481-2023", "product_description": "Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b) 90-count bottle, NDC 61919-0448-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534", "product_quantity": "30 count: 12 bottles; 90 count: 253 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230313", "center_classification_date": "20230324", "termination_date": "20240617", "report_date": "20230405", "code_info": "a) [30 count bottles] Lot, expiry:  21JU2112 , exp 9/30/2023   b) [90 count bottles] Lot, expiry: 22DE2113 , exp 1/31/2024;  27JA2235 , exp 3/31/2024;  05AP2224 , exp 7/31/2024 ;  06AU2104 , exp 1/31/2024 ;  08JU2215 , exp 9/30/2024 ;  209AU2109 , exp 1/31/2024 ;  15JU2113 , exp 9/30/2023 ;  21FE2217  , exp 4/30/2024 ;  21OC2115 , exp 2/29/2024 ;  23JY2144  , exp 1/31/2024 ;  25JU2124 , exp 9/30/2023 ;  29AP2219 , exp 7/31/2024 ;  07DE2128 , exp 3/31/2024 ."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0572-2019", "product_description": "Dr. King's Natural Medicine Homeopathic PMS Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955500926, NDC 57955-5009-2", "product_quantity": "1018 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 050216J Exp. 05/19; 080416C Exp. 08/19; 081815K Exp. 08/18"}, {"status": "Completed", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-538"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235"], "spl_id": ["102d1826-981f-0ebc-e063-6294a90a4acc"], "spl_set_id": ["14f80ad5-37cc-4672-9caa-2dd2f469af0a"], "package_ndc": ["60687-538-11", "60687-538-21"], "original_packager_product_ndc": ["47335-721"], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "93918", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0314-2024", "product_description": "Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11", "product_quantity": "1,932 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240125", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot # 1015033, exp. 06/30/2025; 1016409, exp. 08/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091023"], "brand_name": ["CLOPIDOGREL BISULFATE"], "generic_name": ["CLOPIDOGREL BISULFATE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-671"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOPIDOGREL BISULFATE"], "rxcui": ["749196"], "spl_id": ["e74780f8-a035-e6a0-b457-c04edd4162bf"], "spl_set_id": ["4da4da53-91ae-4d4f-145f-255c5db443a5"], "package_ndc": ["55111-671-30", "55111-671-90", "55111-671-01", "55111-671-05", "55111-671-48", "55111-671-79", "55111-671-81", "55111-671-06", "55111-671-31", "55111-671-78"], "is_original_packager": [true], "unii": ["08I79HTP27"]}, "product_type": "Drugs", "event_id": "81530", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A.nationwide", "recall_number": "D-0283-2019", "product_description": "Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31", "product_quantity": "4,212 (30-count blister pack)", "reason_for_recall": "Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.", "recall_initiation_date": "20181107", "center_classification_date": "20181127", "termination_date": "20200519", "report_date": "20181128", "code_info": "Lot #: T600530, Exp 11/18", "more_code_info": ""}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0217-2023", "product_description": "LEVEMIR-STS- 100U/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221116@36", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "4", "code_info": "L5017 Exp 10/31/13, C51301 Exp 9/30/13, B5312 Exp 8/31/13, and A5209 Exp 11/01/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-772-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97684", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0002-2026", "product_description": "Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.", "product_quantity": "600 30-count bottles", "reason_for_recall": "Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity", "recall_initiation_date": "20250924", "center_classification_date": "20251002", "report_date": "20251008", "code_info": "Lot#: E409309, Exp 12/31/2026"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0554-2022", "product_description": "DBI Magnums Tablet (Caffeine 200 mg) 100 and 500 count & 3 and 36 count packets & Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY   NDC 62959-941-00", "product_quantity": "8,727,657 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M941L M940LA  Bulk Lots: 19C065, 19F081, 19H083, 17D088"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0213-2019", "product_description": "Testosterone in Grapeseed Oil 200 mg/mL, a) 4 mL, b) 5 mL, c) 10 mL and d) 30 mL Injectable, Pharm D Solutions, Houston, Texas NDC 69699-1702-05", "product_quantity": "a) 4397, b) 4885 c) 1319, d) 4112 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a)  Lot: 01302018:77/A Discard by: 1/25/2019; 09042017:74/B Discard by: 8/30/2018; 04042018:51/A Discard by: 3/31/2019; 05152018:94/A Discard by: 5/9/2019; 07022018:04/A Discard by: 6/27/2019; 07162018:80/B Discard by: 7/11/2019; 08272018:15/B Discard by: 8/22/2019; b) 12052017:13/B, Discard by: 11/30/2018; 09042017:74/A Discard by: 8/30/2018; 03212018:39/B Discard by: 3/17/2019; 01302018:77/B Discard by: 1/25/2019; 06262018:25/A Discard by: 6/21/2019; 05212018:45/A Discard by: 5/16/2019; 05152018:94/B Discard by: 5/9/2019; 07162018:80/A Discard by: 7/11/2019 c)  Lot: 09132017:58/A Discard by: 9/7/2018; 03212018:39/P Discard by: 3/16/2019; 05012018:45/A Discard by: 4/26/2019; 05012018:45/P Discard by: 4/26/2019; 06042018:58/A Discard by: 5/30/2019; 05152018:94/C Discard by: 5/9/2019; 07022018:04/B Discard by: 6/27/2019 d)  Lot: 01082018:40/B Discard by: 1/3/2019; 09042017:74/C Discard by: 8/30/2018; 09132017:58/B Discard by: 9/7/2018; 01302018:77/C Discard by: 1/25/2019; 03212018:39/C Discard by: 3/16/2019; 04042018:51/B Discard by: 3/30/2019; 06042018:58/B Discard by: 5/30/2019; 05012018:45/B Discard by: 4/26/2019; 06132018:02/B Discard by: 6/3/2019; 05212018:94/B Discard by: 5/9/2019; 05152018:94/D Discard by: 5/9/2019; 07162018:80/C Discard by: 7/11/2019; 08062018:67A Discard by: 8/1/2019; 07022018:04/C Discard by: 6/27/2019; 07242018:04/A Discard by: 7/19/2019; 08272018:15/A Discard by: 8/22/2019"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0439-2022", "product_description": "Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10%/10%/4% Raspberry Marshmallow, 30 grams per jar, Multiple Dose Container For Topical Oral Use,Edge Pharma LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0790-10", "product_quantity": "353 jars", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "07-2021-20@7 01-16-2022,  08-2021-11@6 02-07-2022, 08-2021-31@11 02-01-2022,  09-2021-14@11 02-01-2022, 09-2021-21@6 02-01-2022 & 10-2021-12@4 04-10-2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202557"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-200", "16729-203", "16729-289", "16729-201", "16729-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866090", "866094", "866111"], "spl_id": ["4092e48b-b3d6-abf3-e063-6394a90afe61"], "spl_set_id": ["3da22999-f5fb-49fd-acde-c3006598e985"], "package_ndc": ["16729-203-12", "16729-203-01", "16729-203-59", "16729-203-16", "16729-203-17", "16729-289-12", "16729-289-01", "16729-289-59", "16729-289-16", "16729-289-17", "16729-200-01", "16729-200-16", "16729-200-17", "16729-201-01", "16729-201-16", "16729-201-17", "16729-202-01", "16729-202-16", "16729-202-17"], "is_original_packager": [true], "upc": ["0316729289016", "316729202169"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0378-2023", "product_description": "BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA, NDC 16729-202-16 UPC 3 16729 20216 9", "product_quantity": "3,784 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2105472, Exp. Date 4/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078245"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-215", "68180-216", "68180-217"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["32db19ef-5d4a-4330-93ec-1a8d595e8f2a"], "spl_set_id": ["ee1eaaf6-050b-48af-942b-5e3451edc164"], "package_ndc": ["68180-215-09", "68180-215-03", "68180-215-01", "68180-215-06", "68180-216-06", "68180-216-09", "68180-216-01", "68180-216-03", "68180-217-06", "68180-217-09", "68180-217-01", "68180-217-03"], "is_original_packager": [true], "upc": ["0368180215066", "0368180217060"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "89916", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide", "recall_number": "D-0843-2022", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg  a) 30-count bottles (NDC# 68180-216-06)  b) 90-count bottles (NDC# 68180-216-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA", "product_quantity": "2,361,924 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220331", "center_classification_date": "20220503", "termination_date": "20230522", "report_date": "20220511", "code_info": "Lot #  H001878 6/30/2022 68180-216-06  H002178 7/31/2022 68180-216-06  H002626 9/30/2022 68180-216-06  H102149 9/30/2023 68180-216-06  H001600 5/31/2022 68180-216-09  H001601 5/1/2022         68180-216-09  H001625 5/31/2022 68180-216-09  H001626 5/31/2022 68180-216-09  H001794 6/30/2022 68180-216-09  H001795 6/30/2022 68180-216-09  H001796 6/30/2022 68180-216-09  H001797 6/30/2022 68180-216-09  H001879 6/30/2022 68180-216-09  H001880 6/30/2022 68180-216-09  H001881 6/30/2022 68180-216-09  H001942 6/30/2022 68180-216-09  H001943 6/30/2022 68180-216-09  H001944 6/30/2022 68180-216-09  H001945 6/30/2022 68180-216-09  H001946 6/30/2022 68180-216-09  H002179 7/31/2022 68180-216-09  H002180 7/31/2022 68180-216-09  H002181 8/31/2022 68180-216-09  H002182 8/31/2022 68180-216-09  H002183 8/31/2022 68180-216-09  H002237 8/31/2022 68180-216-09  H002238 8/31/2022 68180-216-09  H002239 8/31/2022 68180-216-09  H002240 8/31/2022 68180-216-09  H002241 8/31/2022 68180-216-09  H002627 9/30/2022 68180-216-09  H002628 9/30/2022 68180-216-09  H002629 9/30/2022 68180-216-09  H002630 9/30/2022 68180-216-09  H002631 9/30/2022 68180-216-09  H002979 11/30/2022 68180-216-09  H002980 11/30/2022 68180-216-09  H002981 11/30/2022 68180-216-09  H002982 11/30/2022 68180-216-09  H002983 11/30/2022 68180-216-09  H100112 12/31/2022 68180-216-09  H100113 12/31/2022 68180-216-09  H100114 12/31/2022 68180-216-09  H100115 12/31/2022 68180-216-09  H100116 12/31/2022 68180-216-09  H100156 12/31/2022 68180-216-09  H100157 12/31/2022 68180-216-09  H100622 2/28/2023 68180-216-09  H100623 2/28/2023 68180-216-09  H100624 2/28/2023 68180-216-09  H100625 2/28/2023 68180-216-09  H100626 2/28/2023 68180-216-09  H100627 2/28/2023 68180-216-09  H100628 2/28/2023 68180-216-09  H100629 2/28/2023 68180-216-09  H100939 4/30/2023 68180-216-09  H100940 4/30/2023 68180-216-09  H100941 4/30/2023 68180-216-09  H100942 4/30/2023 68180-216-09  H100943 4/30/2023 68180-216-09  H101094 5/31/2023 68180-216-09  H101095 5/31/2023 68180-216-09  H101096 5/31/2023 68180-216-09  H101097 5/31/2023 68180-216-09  H101098 5/31/2023 68180-216-09  H101151 5/31/2023 68180-216-09  H101152 5/31/2023 68180-216-09  H101290 5/31/2023 68180-216-09  H101291 5/31/2023 68180-216-09  H101292 5/31/2023 68180-216-09  H101293 5/31/2023 68180-216-09  H101323 5/31/2023 68180-216-09  H101324 5/31/2023 68180-216-09  H101823 7/31/2023 68180-216-09  H101824 7/31/2023 68180-216-09  H101825 7/31/2023 68180-216-09  H101853 8/31/2023 68180-216-09  H101854 8/31/2023 68180-216-09  H101855 8/31/2023 68180-216-09  H101856 8/31/2023 68180-216-09  H102127 9/30/2023 68180-216-09  H102128 9/30/2023 68180-216-09  H102129 9/30/2023 68180-216-09  H102130 9/30/2023 68180-216-09  H102150 9/30/2023 68180-216-09  H102151 9/30/2023 68180-216-09  H102152 9/30/2023 68180-216-09  H102153 9/30/2023 68180-216-09  H102154 9/30/2023 68180-216-09  H102155 9/30/2023 68180-216-09  H102201 9/30/2023 68180-216-09  H102223 9/30/2023 68180-216-09  H102268 9/30/2023 68180-216-09  H102269 9/30/2023 68180-216-09  H102270 9/30/2023 68180-216-09  H102271 9/30/2023 68180-216-09"}, {"status": "Ongoing", "city": "Carolina", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93159", "recalling_firm": "Omega & Delta Co., Inc.", "address_1": "Carr. 887 Km 0 Hm 8 Julio N. Matos Ind. Park Bldg#10", "address_2": "N/A", "postal_code": "00985", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed in Puerto Rico only.", "recall_number": "D-0105-2024", "product_description": "Equate Hand Sanitizer (Ethyl Alcohol 62%),  7.5 FL.OZ. (221 mL)  UPC 6 81131 05961 9", "product_quantity": "4,848 7.5 oz bottles", "reason_for_recall": "Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.", "recall_initiation_date": "20231020", "center_classification_date": "20231114", "report_date": "20231122", "code_info": "Lot #s 006511"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074984"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-014", "63739-015", "63739-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830837", "830845", "830861"], "spl_id": ["205ba6f0-3a28-153f-e063-6294a90ab9e2"], "spl_set_id": ["2ec2afa8-f91a-46cd-ac4e-b8ffa59015ec"], "package_ndc": ["63739-014-10", "63739-015-10", "63739-016-10"], "original_packager_product_ndc": ["10370-829", "10370-830", "10370-831"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "79936", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd Nw", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide with the US", "recall_number": "D-0716-2018", "product_description": "Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-016-10", "product_quantity": "2966 cartons", "reason_for_recall": "Failed Dissolution Specifications. High dissolution results were obtained during stability testing.", "recall_initiation_date": "20180423", "center_classification_date": "20180507", "termination_date": "20201013", "report_date": "20180502", "code_info": "Lot #: 0115087, Exp. 12/2018"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; FEBUXOSTAT Tablet, 40 mg may be potentially mislabeled as    methylPREDNISolone, Tablet, 4 mg, NDC 59746000103, Pedigree: AD21811_17, EXP: 5/1/2014;  tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: W002663, EXP: 6/5/2014;  SODIUM CHLORIDE, Tablet, 1000 mg, NDC 00527111610, Pedigree: W003926, EXP: 7/1/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "FEBUXOSTAT Tablet, 40 mg has the following codes    Pedigree: AD23082_16, EXP: 11/1/2013;  Pedigree: W002664, EXP: 6/5/2014;  Pedigree: W003927, EXP: 7/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FEBUXOSTAT Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64764091830", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-698-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0892-2016", "product_description": "Zhong Hua Niu Bian, packaged in BIG BOX (6 small boxes / 6 capsules per box / 36 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M003"], "brand_name": ["DERMAKLEEN"], "generic_name": ["ANTIMICROBIAL DRUG PRODUCT"], "manufacturer_name": ["Dermarite Industries LLC"], "product_ndc": ["61924-092"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["1549613", "1549618"], "spl_id": ["2889bd9a-c988-d5f3-e063-6394a90a19b9"], "spl_set_id": ["ff28985e-d941-4350-971f-fdc2dbbb93bb"], "package_ndc": ["61924-092-08", "61924-092-01", "61924-092-34", "61924-092-27", "61924-092-11"], "is_original_packager": [true], "upc": ["0714196098085"], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0610-2025", "product_description": "DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E (Chloroxylenol 0.2%), packaged in a) 800 ml (27 fl. oz.) bag-n-box (NDC 61924-092-27)  and b) 1000ml (34 fl. oz.) bag-n-box (NDC 61924-092-34) , DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.", "product_quantity": "11,321 bag in boxes", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot # and Expiration Date: a) 30550A, Exp. Date 7/2025; 30670A, 30682A, Exp. Date 8/2025; 40025A, Exp. Date 1/2026; 40375A, Exp. Date 4/2026; 40427A, 40436A, Exp. Date 5/2026; 50068A, Exp. Date 1/2027.  b)30586A, 30586B, 30626A, Exp. Date 7/2025; 30628A, 30657A, Exp. Date 8/2025;   30741A, Exp. Date 7/2025; 30871A, Exp. Date 10/2025; 40002A, Exp. Date 12/2025; 40012A, Exp. Date 1/2026; 40301A, Exp. Date 3/2026; 40789 A, Exp. Date 9/2026; 50068B, Exp. Date 1/2027; 50144A, 50149A, Exp. Date 2/2027."}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0929-2016", "product_description": "Meropenem 2 grams in 100 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "22 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"country": "United States", "city": "Hawthorne", "address_1": "3 Skyline Dr", "reason_for_recall": "Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.", "address_2": "", "product_quantity": "", "code_info": "Lot # 313344, Exp 12/18", "center_classification_date": "20181120", "distribution_pattern": "Nationwide in the USA", "state": "NY", "product_description": "children's allergy relief (cetirizine hydrochloride) oral solution, 1 mg/mL, Dye Free, Sugar Free, Alcohol Free, 4 FL OZ (120 mL) bottle, Distributed by Rite-Aid, 30 Hunter Lane, Camp Hill, PA 17011, Made in Israel, UPC 0 11822 57363 4.", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "recall_number": "D-0278-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81483", "termination_date": "20201103", "more_code_info": "", "recall_initiation_date": "20181019", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Pleasanton", "address_1": "39 California Ave Ste 104", "reason_for_recall": "Labeling: Not Elsewhere Classified:  due to a labeled declaration of; Store at 15\u00bfC to 30\u00bfC (59\u00bfF to 86\u00bfF) which differs from the original manufacturer declaration of; Store at 20\u00bfC to 25\u00bfC (68\u00bfF to 77\u00bfF).", "address_2": "", "product_quantity": "199 tablets in 20-count containers", "code_info": "Lot # 0130130 EXP 12/31/20", "center_classification_date": "20180514", "distribution_pattern": "California.", "state": "CA", "product_description": "Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containers, Rx Only. Mnfct for: Mallinckrodt Inc. Hazelwood, MO 63042. Mnfct by:Mallinckrodt Inc. Hazelwood, MO 63042. Pckgd by PreScript Pharm Inc. Pleasanton, CA 94566 NDC: 00406-0484-10 Bar Code 0078-20-1834", "report_date": "20180523", "classification": "Class II", "openfda": {}, "recalling_firm": "Prescript Pharmaceuticals, Inc.", "recall_number": "D-0809-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79961", "termination_date": "20190123", "more_code_info": "", "recall_initiation_date": "20180424", "postal_code": "94566-6279", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200923"], "brand_name": ["GYNAZOLE 1"], "generic_name": ["BUTOCONAZOLE NITRATE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-396"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["VAGINAL"], "substance_name": ["BUTOCONAZOLE NITRATE"], "rxcui": ["890785", "890786"], "spl_id": ["3953738b-1476-4a24-9e07-a7d3866d76a8"], "spl_set_id": ["125d8ede-db38-4eb9-a6be-19208687f36a"], "package_ndc": ["45802-396-01", "45802-396-02"], "is_original_packager": [true], "unii": ["4805237NP5"]}, "product_type": "Drugs", "event_id": "93189", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0081-2024", "product_description": "Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010.  NDC: 45802-396-01", "product_quantity": "10,512 cartons", "reason_for_recall": "Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.", "recall_initiation_date": "20230928", "center_classification_date": "20231031", "report_date": "20231108", "code_info": "Lot#: 164185, Exp. Date 4/2024"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-080-2014", "product_description": "Double Strength PGE1 40mcg 2ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-632-2013", "product_description": "Acetylcysteine 10 % Solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "300ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCAFBA:73, Exp date: 9/30/2013"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0382-2016", "product_description": "Thiotic Acid Injection, 25mg/mL, 30mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "7 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1430-2022", "product_description": "MEDIC EYE DROPS MAX REDNESS SKU 998920   CLR EYS MX RDNS RLIF 0.5 FL OZ SKU 901844   SYSTANE ULTRA HIGH PRFRM LUB DRPS 0.14 FLOZ SKU 901961   LUMIFY REDNESS REL EYE DROPS 2.5 FL OZ\tSKU 998300   FC EYE DROPS ADVANCED 0.5 OZ SKU 902280 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 998920; 901844; 901961; 998300; 902280", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1148-2019", "product_description": "HCG 20 Day Injection, 2625 Units/4 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "217 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2580", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Propofol1% 10mg/mL injection,  20 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0119-73", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1264-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0035-2022", "product_description": "CYCLOSPORINE 2% MCT OIL SUSP, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1363-2016", "product_description": "0.1 mg/mL Morphine Sulfate and 0.05% Bupivacaine HCI (Preservative Free) in 0.9%, 150 mL in 250 mL Hospira LifeCare Bag, Service Code 2H9994\t, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-994-83", "product_quantity": "15 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number: 160700041M; Exp. Date 6/8/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0811-2022", "product_description": "QM-3, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 150 mcg/mL . Atropine 0.2 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0019-10.", "product_quantity": "1679 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E42B12 BUD: 5/12/2022, E42C12 BUD: 5/12/2022, E42D12 BUD: 5/12/2022, H24B23 BUD: 8/23/2022, H24C23 BUD: 8/23/2022, H24D23 BUD: 8/23/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80000", "recalling_firm": "Vitalab Pharmacy, Inc", "address_1": "4045 E Bell Rd Ste 163", "address_2": "N/A", "postal_code": "85032-2240", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled product was distributed to patients throughout the United States.", "recall_number": "D-0731-2018", "product_description": "Methionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml, Sterile injectable, Vitalab Pharmacy, Inc", "product_quantity": "3 vials", "reason_for_recall": "Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.", "recall_initiation_date": "20180424", "center_classification_date": "20180509", "termination_date": "20200123", "report_date": "20180516", "code_info": "Lot #: 03052018@54, Exp 06/03/2018"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0183-2022", "product_description": "TESTOSTERONE CYPIONATE 30MG/ML #1  IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T0504202021:26 BUD: 10/17/2021", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "33 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03042015@15, 6/2/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Methylcobalamin 5,000 mcg/ml Injectable,  Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1572-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97372", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0587-2025", "product_description": "Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India.  Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430, NDC 68462-164-05", "product_quantity": "17, 496 bottles", "reason_for_recall": "CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm", "recall_initiation_date": "20250806", "center_classification_date": "20250814", "report_date": "20250820", "code_info": "Lot #: 17241257, 17241258, 17241279, Exp. Date 06/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0693-2020", "product_description": "BUP 20MG/SUF 1000MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@10 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0317-2018", "product_description": "Medline Suture Removal Tray,  Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "9,000 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: SD-1010; Lots 17CB8694; 17MB4778; 16KB5621", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-094-2014", "product_description": "Estradiol Pellets 31mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "7 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87093", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0243-2021", "product_description": "Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC Bridgewater, NJ 08807 USA NDC 0187-1704-05", "product_quantity": "895 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.", "recall_initiation_date": "20210107", "center_classification_date": "20210125", "termination_date": "20220211", "report_date": "20210203", "code_info": "Lot: 18L092P, Exp 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0460-2019", "product_description": "HCG, Human chorionic gonadotropin 11,000 units, injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "654 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 06182018@5 BUD: 12/15/2018; 07102018@5 BUD: 1/6/2018; 08212018@8 BUD: 2/17/2019"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1005-2013", "product_description": "TRI-MIX 10 MCG/30 MG/1 MG/ML INJ SOLN and TRI-MIX 30 MCG/15 MG/2 MG/ML INJ SOLN, all configuration, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "04302013@22, 02132013@8, 04122013@27, 06262013@28", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0182-2019", "product_description": "Sermorelin/GHRP-2 9 mg-6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1728-10", "product_quantity": "330 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03202018:06 Discard by: 9/16/2018; 06112018:49 Discard by: 12/8/2018"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1053-2015", "product_description": "DNCB 0.3% Ointment, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}]